LYVDELZI caps 10 mg 30 pce

7680700630016 CH-70063 A05AX07 04.99.0.

No images available

Details

Product number
7006301
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
seladelparum 10 mg ut seladelparum lysinum dihydricum, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.42 mg, magnesii stearas, silica colloidalis anhydrica, E 321, Kapselhülle: gelatina, E 171, E 172 (nigrum), E 172 (flavum), E 172 (rubrum), E 132, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), Drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, E 171, pro capsula.

Articles (1)

Lyvdelzi 10 mg, Hartkapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
20/12/2025
Patient information leaflet
Français
20/12/2025
Patient information leaflet
Italien
20/12/2025
Professional SmPC
Allemand
20/12/2025
Professional SmPC
Français
20/12/2025
Professional SmPC
Italien
20/12/2025

Detailed composition

Substance Quantity Type Category
seladelparum
10.0 MG Substance Wirkstoff (Principe actif)
seladelparum lysinum dihydricum
- Substance WIZUS
mannitolum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
0.42 MG Substance HBESI
magnesii stearas
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
E 321
- Substance ANTOX
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (nigrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 132
- Substance FIMDK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
kalii hydroxidum
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrii hydroxidum
- Substance HNIDK
povidonum
- Substance HNIDK
E 171
- Substance FNIDK

Authorization holder

Gilead Sciences Switzerland Sàrl

6300 Zug

Authorization information

Swissmedic authorization number
70063
Drug name
Lyvdelzi, Hartkapseln
Galenic form
KAHA
ATC Code
A05AX07
Authorization status
B
Dispensation category
A
First authorization
09/12/2025
Authorization expiration date
09/12/2027
IT number
04.99.0.
Domain
Human medicine
Field of application
Behandlung der primären biliären Cholangitis

Packaging details

Description (FR)
LYVDELZI caps 10 mg 30 pce
Description (DE)
LYVDELZI Kaps 10 mg 30 Stk
Market launch
12/01/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data